{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:15:40Z","timestamp":1789168540915,"version":"build-2803163510"},"reference-count":4,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaad.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:12:03Z","timestamp":1775315523000},"page":"e173-e175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Managing injectable triamcinolone acetonide shortages in dermatology"],"prefix":"10.1016","volume":"95","author":[{"given":"Jia Qi Adam","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn","family":"Sibbald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8623-2974","authenticated-orcid":false,"given":"Jeffrey","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.04.004_bib1","series-title":"Medicine Supply Notification: Triamcinolone Acetonide 10 mg\/mL (Adcortyl\u00ae) Ampoules and 40 mg\/mL (Kenalog\u00ae) Suspension for Injection","year":"2025"},{"issue":"2","key":"10.1016\/j.jaad.2026.04.004_bib3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/09546634.2020.1788703","article-title":"Intralesional betamethasone versus triamcinolone acetonide in the treatment of localized alopecia areata: a within-patient randomized controlled trial","volume":"33","author":"De Sousa","year":"2022","journal-title":"J Dermatol Treat"},{"issue":"8","key":"10.1016\/j.jaad.2026.04.004_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/09546634.2017.1329497","article-title":"Best dilution of the best corticosteroid for intralesional injection in the treatment of localized alopecia areata in adults","volume":"28","author":"Ustuner","year":"2017","journal-title":"J Dermatol Treat"},{"issue":"10","key":"10.1016\/j.jaad.2026.04.004_bib5","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4314\/tjpr.v23i10.10","article-title":"Comparative efficacy and clinical outcomes of compound betamethasone and triamcinolone acetonide on IL-6 and IL-17 in keloid treatment","volume":"23","author":"Chen","year":"2024","journal-title":"Trop J Pharm Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226005219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226005219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:37:30Z","timestamp":1784288250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226005219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0190962226005219"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.04.004","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing injectable triamcinolone acetonide shortages in dermatology","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}